Jefferies Assumes Paratek Pharmaceuticals (PRTK) at Buy, Sees 216% Upside
Tweet Send to a Friend
(Updated - May 2, 2023 8:58 AM EDT)
Jefferies analyst Kambiz Yazdi assumed coverage on Paratek Pharmaceuticals (NASDAQ: PRTK) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Kambiz Yazdi assumed coverage on Paratek Pharmaceuticals (NASDAQ: PRTK) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
